UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 17,
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Boundless Bio Charts.
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Boundless Bio Charts.

News Audentes Therapeutics, Inc.

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Mittwoch 5 Juni 2024 (2 Tage vor) • Business Wire
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)
Form 8-K - Current report
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
Montag 13 Mai 2024 (4 Wochen vor) • Business Wire
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
Montag 6 Mai 2024 (1 Monat vor) • Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
Donnerstag 11 April 2024 (2 Monate vor) • Business Wire
Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
Montag 8 April 2024 (2 Monate vor) • Business Wire

Weitere Audentes Therapeutics, Inc. News-Artikel